Recruiting Waldenstrom Macroglobulinemia Studies in Denver
About Waldenstrom Macroglobulinemia Clinical Trials in Denver
Waldenstrom macroglobulinemia is a rare type of non-Hodgkin lymphoma where cancer cells produce large amounts of an abnormal protein called macroglobulin. It progresses slowly and may not require immediate treatment. Options include targeted therapy, chemotherapy, and plasmapheresis.
There are currently 1 waldenstrom macroglobulinemia clinical trials recruiting participants in Denver, CO. These studies are seeking a combined 65 participants. Research is being sponsored by Massachusetts General Hospital. Clinical trial participation is free and participants receive study-related medical care at no cost.
Waldenstrom Macroglobulinemia Clinical Trials in Denver — FAQ
Are there waldenstrom macroglobulinemia clinical trials in Denver?
Yes, there are 1 waldenstrom macroglobulinemia clinical trials currently recruiting in Denver, CO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Denver?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Denver research site will contact you about next steps.
Are clinical trials in Denver free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Denver studies also compensate for your time and travel.
What waldenstrom macroglobulinemia treatments are being tested?
The 1 active trials in Denver are testing new therapies including novel drugs, biologics, and treatment approaches for waldenstrom macroglobulinemia.
Data updated October 18, 2026 from ClinicalTrials.gov